CompletedPhase 2NCT01245127

Ilaris (Canakinumab) in the Schnitzler Syndrome

Studying Schnitzler syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Universitaire Ziekenhuizen KU Leuven
Principal Investigator: Steven Vanderschueren, MD, PhD
General Internal Medicine, UZ Gasthuisberg, Leuven
Intervention: Ilaris(drug)
Enrollment: 1 target
Eligibility: 18-85 years · All sexes
Timeline: 2011 – 2012

Study locations (1)

UZ Gasthuisberg, Leuven, Belgium

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01245127 on ClinicalTrials.gov

← Back to all trials